Get Into Express Scripts in a Hurry

by Sam Collins | July 20, 2012 2:30 am

Express Scripts (NASDAQ:ESRX[1]) — This company provides healthcare management and administration services for HMOs, health insurers and various compensation plans and systems. Yesterday it ended an extended dispute[2] with Walgreens (NYSE:WAG[3]) over rates and returns. Analysts now project that both companies will benefit, but several analysts reaffirmed their earnings target of $4.60 for 2013 vs. $3.66 this year with a price target of $66.

ESRX broke from a double top at just above $58 yesterday following the crossing of the 20-day moving average through the 50-day moving average last week. The trading target from the breakout is $66. Investors may buy ESRX as a quality long-term hold in the health care management industry.

Trade of the Day Chart Key

  1. ESRX:
  2. ended an extended dispute:
  3. WAG:

Source URL:
Short URL: